Insider Selling: AmerisourceBergen Corporation (Holding Co) (ABC) SVP Sells $1,393,995.22 in Stock
AmerisourceBergen Corporation (Holding Co) (NYSE:ABC) SVP Lazarus Krikorian sold 16,427 shares of the business’s stock in a transaction dated Thursday, November 30th. The stock was sold at an average price of $84.86, for a total value of $1,393,995.22. Following the completion of the transaction, the senior vice president now owns 23,360 shares in the company, valued at approximately $1,982,329.60. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.
Shares of AmerisourceBergen Corporation (NYSE ABC) opened at $85.99 on Thursday. AmerisourceBergen Corporation has a one year low of $71.90 and a one year high of $97.85. The stock has a market capitalization of $18,731.06, a P/E ratio of 14.58, a price-to-earnings-growth ratio of 1.49 and a beta of 1.00. The company has a current ratio of 0.91, a quick ratio of 0.48 and a debt-to-equity ratio of 1.83.
AmerisourceBergen (NYSE:ABC) last announced its quarterly earnings data on Thursday, November 2nd. The company reported $1.33 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.32 by $0.01. The firm had revenue of $39.12 billion for the quarter, compared to analysts’ expectations of $40.10 billion. AmerisourceBergen had a return on equity of 56.29% and a net margin of 0.27%. AmerisourceBergen’s revenue for the quarter was up 4.2% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.30 earnings per share. equities research analysts expect that AmerisourceBergen Corporation will post 6.07 EPS for the current fiscal year.
Several research firms recently commented on ABC. Cowen upgraded AmerisourceBergen from a “market perform” rating to an “outperform” rating in a research note on Tuesday, October 10th. Jefferies Group set a $85.00 price target on AmerisourceBergen and gave the stock a “hold” rating in a research note on Sunday, October 29th. Zacks Investment Research cut AmerisourceBergen from a “hold” rating to a “sell” rating in a research note on Tuesday, October 3rd. Robert W. Baird set a $99.00 price target on AmerisourceBergen and gave the stock a “buy” rating in a research note on Friday, December 1st. Finally, Morgan Stanley cut AmerisourceBergen from an “overweight” rating to an “equal weight” rating in a research note on Thursday, September 14th. One analyst has rated the stock with a sell rating, seven have given a hold rating, seven have issued a buy rating and one has given a strong buy rating to the company. The company presently has a consensus rating of “Buy” and an average price target of $91.95.
Several institutional investors have recently made changes to their positions in the company. Burgundy Asset Management Ltd. raised its position in shares of AmerisourceBergen by 1.9% during the 3rd quarter. Burgundy Asset Management Ltd. now owns 2,698,948 shares of the company’s stock worth $223,338,000 after purchasing an additional 49,825 shares during the period. Steward Partners Investment Advisory LLC acquired a new stake in shares of AmerisourceBergen during the 3rd quarter worth approximately $364,000. Coastline Trust Co raised its position in shares of AmerisourceBergen by 37.2% during the 3rd quarter. Coastline Trust Co now owns 2,950 shares of the company’s stock worth $244,000 after purchasing an additional 800 shares during the period. Gyroscope Capital Management Group LLC raised its position in shares of AmerisourceBergen by 9.3% during the 3rd quarter. Gyroscope Capital Management Group LLC now owns 67,695 shares of the company’s stock worth $5,602,000 after purchasing an additional 5,773 shares during the period. Finally, IFM Investors Pty Ltd acquired a new stake in shares of AmerisourceBergen during the 3rd quarter worth approximately $406,000. Institutional investors and hedge funds own 67.83% of the company’s stock.
AmerisourceBergen Corporation is a pharmaceutical sourcing and distribution services company. The Company’s segments include Pharmaceutical Distribution and Other. The Company provides services to healthcare providers, and pharmaceutical and biotech manufacturers. As of June 30, 2016, the Pharmaceutical Distribution segment consists of two operating segments, including the operations of AmerisourceBergen Drug Corporation (ABDC) and AmerisourceBergen Specialty Group (ABSG), which distributes specialty drugs to their customers.
Receive News & Ratings for AmerisourceBergen Corporation (Holding Co) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AmerisourceBergen Corporation (Holding Co) and related companies with MarketBeat.com's FREE daily email newsletter.